Previously, we identified that liver PRMT6 levels negatively correlate with liver fibrosis in patients with liver disease.23 Here, we found that PRMT6 regulates weight gain and liver steatosis, while its effect on fibrosis is sex dependent and mediated by estrogen signaling. This evidence concerns the gene PRMT6 and liver disorder.